Exhibit 99.2
FORM 51-102F3
Material Change Report
| Item 1 | | Name and Address of Company |
| | | |
| | | IMRIS Inc. (the “Company ”) |
| | | 100 - 1370 Sony Place |
| | | Winnipeg, Manitoba |
| | | Canada, R3T 1N5 |
| | | |
| Item 2 | | Date of Material Change |
| | | |
| | | February 13, 2014 |
| | | |
| Item 3 | | News Release |
| | | |
| | | News release attached as Schedule “A” was disseminated on February 13, 2014 via Canada NewsWire. |
| | | |
| Item 4 | | Summary of Material Change |
| | | |
| | | On February 13, 2014, the Company announced US Food and Drug Administration clearance of the newest generation VISIUS® Surgical Theatre which integrates Siemens’ latest high-field MR scanners. |
| | | |
| Item 5 | | Full Description of Material Change |
| | | 5.1 | Full Description of Material Change |
| | | | |
| | | See news release attached hereto as Schedule “A” dated February 13, 2014. |
| | | | |
| | | 5.2 | Disclosure for Restructuring Transactions |
| | | | |
| | | N/A |
| Item 6 | | Reliance on subsection 7.1(2) or (3) of National Instrument 51-102 |
| | | |
| | | N/A |
| | | |
| Item 7 | | Omitted Information |
| | | |
| | | N/A. |
| | | |
| Item 8 | | Executive Officer |
| | | Name of Executive Officer: | Kelly McNeill |
| | | Title: | Executive Vice President Finance & CFO |
| | | Telephone Number: | 763-203-6304 |
| Item 9 | | Date of Report |
| | | |
| | | February 13, 2014 |
Schedule “A”
 | FOR IMMEDIATE RELEASE |
IMRIS receives FDA clearance for next generation VISIUS Surgical Theatre
Most advanced Siemens MR scanners provide highest intraoperative image quality and best workflow available
MINNEAPOLIS, February 13, 2014 -IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the “Company”) today announced US Food and Drug Administration clearance of the newest generation VISIUS® Surgical Theatre which integrates Siemens’ latest high-field MR scanners.
The new core imaging technology based on Siemens Aera 1.5T(tesla) and Skyra 3.0T technology helps IMRIS deliver better image quality with higher signal-to-noise ratio, faster 3D image acquisition, and improved ease-of-use and workflow during neurosurgical procedures using intraoperative MRI (iMRI).
“These high-field intraoperative scanner options will give a hospital’s clinical team imaging applications and image quality that increase productivity,” said IMRIS President and CEO Jay D. Miller. “We are bringing the latest and unequaled imaging technology into the operating room where it can make the most difference - during the surgery. IMRIS systems have been used in over 13,000 cases worldwide to improve outcomes in brain tumor and epilepsy surgeries in particular.”
The addition of these MR systems expands the industry-leading 1.5T and 3.0T MRI choices hospitals have when considering the unique, ceiling-mounted IMRIS solution for intraoperative imaging which brings the MRI to the patient during the procedure.
The first installation of this new generation VISIUS Surgical Theatre will be a four-room hybrid operating room suite, known as the Center for Surgical Innovation (CSI) at Dartmouth-Hitchcock Medical Center in Lebanon, NH. “Surgeons are too often limited by what they cannot see - anatomy that is difficult to reach or diseases that are not visible to the naked eye,” says Sohail Mirza MD, medical director of CSI and chair of orthopedics at Dartmouth-Hitchcock. “The advanced integration of state-of-the-art imaging tools in CSI will allow surgeons and engineers to innovate like never before, rapidly developing, testing, and validating new surgical tools and techniques, with the goal of achieving better, safer, and, in some cases, less-costly care for patients everywhere.”
The Dartmouth-Hitchcock installation will also include a VISIUS intraoperative CT (iCT), which utilizes the technology of the 64-slice Siemens SOMATOM® Definition AS scanner, making it the only operating suite in the world with both VISIUS iMRI and iCT modalities able to serve multiple operating rooms (ORs) without moving the patient.
Inside a VISIUS Surgical Theatre equipped with either high-field iMRI or iCT, surgeons have on-demand access to real-time data and state-of-the-art imaging, during the procedure from the OR table. The Company also designs and manufactures proprietary head fixation devices, imaging coils, and OR tables for use in this unique and multifunctional intraoperative environment.
About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment.The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, spinal, cardiovascular and cerebrovascular markets and have been selected by 56 leading medical institutions around the world.
For further information, please contact:
| | |
Kevin J. Berger Marketing Communications Manager IMRIS Inc. | |
Tel: 763-203-6332 Email: kberger@imris.com | |
